Wednesday 21 October 2020 14:00 - 16:00 BRUSSELS TIME (CET)

COCIR VIRTUAL SESSION

CAN WE IMPROVE THE FUTURE OF BREAST CANCER CARE IN THE EU? TAKING PLACE DURING THE EUROPEAN BREAST CANCER MONTH

IN PARTNERSHIP WITH

SESSION PROGRAMME & SPEAKERS OVERVIEW

Wednesday 21 October 2020 14:00 - 16:00 BRUSSELS TIME (CET)

COCIR, the European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry In April 2020, the European Commission published the roadmap for its “Europe’s Beating Cancer Plan” 1. In its section on early detection, the European Commission suggests revising the three cancer screening programmes listed in the respective Council Recommendation from 2003.

More than 15 years after the publication of these recommendations, the practice of breast cancer screening has indeed evolved - nonetheless, there are many aspects with regards to access to and quality of breast cancer screening programmes that can be improved in the light of clinical as well as technological innovations:

How can we leverage the opportunities provided by digital solutions basically unknown 15 years ago? How can women benefit from more individualized, personalized risk profiles and treatment options? How can we adapt and further strengthen the compliance to European guidelines across Member States? What investments are needed to ensure access to screening in every corner of the European Union?

This event aims to discuss specific recommendations for the translation of the Europe Beating Cancer Plan into impactful actions on the ground to the benefit of women, healthcare professionals and healthcare systems alike.

1. https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/12154-Europe-s-Beating-Cancer-Plan

2 COCIR BREAST CANCER CARE 2020 OBJECTIVES • Learn more on what EU Institutions are doing.

• Discuss with policy makers, academia, patient organizations and industry on best way to improve the future of breast cancer.

• Learn on latest technology innovations in breast cancer screening.

• Better understand how breast cancer is considered in the frame of the EU Beating Cancer Plan.

AGENDA 14:00 - 14:05 Setting the scene from the moderator Robert MADELIN, Chairman of Fipra International Ltd 14:05 - 14:10 WELCOME INTRODUCTION Dr. Bernt BIEBER, COCIR President

PART 1 KEYNOTES 14:10 - 15:05 KEYNOTE OPENING Mr John-F. RYAN, Director, European Commission - Directorate-General for Health and Food Safety

WHAT ARE PATIENTS EXPECTING? A PERSONAL TESTIMONIAL Lydie MEHEUS, PhD and Managing Director at Anticancer Fund

WHAT IS THE EUROPEAN PARLIAMENT DOING? Chrysoula ZACHAROPOULOU, Member of the MEPs Against Cancer Interest Group

INTERACTIVE SESSION WITH PARTICIPANTS

PART 2 MULTISTAKEHOLDER PANEL DISCUSSION 15:05 - 15:50 HOW TO ENSURE THAT PATIENTS ARE SWIFTLY AND PROPERLY INFORMED? Lydie MEHEUS

WHAT ARE THE HURDLES OF KNOWLEDGE FROM THE SCIENTIFIC SOCIETIES? Prof. Francesco SARDANELLI, Professor of Radiology, University of Milan, Research Hospital Policlinico San Donato, Milan, Italy Prof. Christiane KUHL, Chairman of the Department of Diagnostic and Interventional Radiology at the University Hospital Aachen (UKA), Germany Prof. Youlia KIROVA, M.D., Associate Professor of Radiation Oncology, Curie Institute, Paris, France

HOW CAN MEDICAL TECHNOLOGIES SUPPORT PREVENTION, DIAGNOSIS AND TREATMENT? Dr. Christian STOECKIGT, COCIR Member and Hologic Christine MUZEL, COCIR Value in Health Focus Group Vice-Chair and Philips

INTERACTIVE SESSION WITH PARTICIPANTS

PART 3 CONCLUDING REMARKS 15:50 - 16:00 Nicole DENJOY, COCIR Secretary General and Annemijn ESCHAUZIER, COCIR Value in Health Focus Group Chair and GE Healthcare

PUBLICATIONS • July 2020: COCIR Paper on cancer • June 2019: The Life Savers Study • Lydie Meheus Blog: https://www.anticancerfund.org/en/blog/how-date-are-evidence-based-cancer-treatments

3 COCIR BREAST CANCER CARE 2020 COCIR MODERATOR

MODERATOR

Robert MADELIN

CHAIRMAN AT FIPRA INTERNATIONAL LTD Robert is the Chairman of Fipra International Ltd, and a Visiting Research Fellow at the University of Oxford’s Centre for Technology and Global Affairs. Previously (2004-16) Robert was a senior leader at the European Commission: as Senior Adviser for Innovation, as Director General for Communications Networks, Content and Technology (CONNECT) and as Director General for Health and Consumer Policy (SANCO).

Robert was also a negotiator for 20 years in international trade and investment, first for the UK, and then for the EU: Robert served notably in the Cabinet of European Commission Vice-President Leon Brittan. Robert studied at Magdalen College (1976-9) and at the French Civil Service College (ENA). He is an Honorary Doctor of the University of Edinburgh and an Honorary Fellow of the Royal College of Physicians of London. Robert is the author of ‘Opportunity Now: Europe’s Mission to Innovate’ (2016)

4 COCIR BREAST CANCER CARE 2020 COCIR SPEAKERS

SPEAKERS

Dr. Bernt BIEBER

COCIR PRESIDENT AND SENIOR VICE PRESIDENT DIRECT SALES AT SIEMENS HEALTHINEERS Bernt Bieber is responsible for global direct business of Germany based Siemens Healthcare GmbH with large international end customers and distributors, focus on EMEA.

He has 30+ years experience in various management positions with Siemens Healthineers in Sales and Marketing, including international key account management, global sales responsibility for Magnetic Resonance systems and area sales management in Germany. He also spent 3 years as expatriate manager in USA.

From 2009 to 2011, Bernt Bieber was a member of the advisory board of „Initiative Gesundheitswirtschaft Rhein-Main“, an initiative to increase public awareness of the economic impact of healthcare industry in Frankfurt area.

He holds a Doctorate in Social- and Economic Sciences.

John-F. RYAN

DIRECTOR, EUROPEAN COMMISSION - DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY - DEPUTY John F. Ryan is Director of the Commission Public Health, country knowledge, crisis management directorate since September 2016. Previously, in the same department, he was the Head of Unit responsible for a number of public health policy areas (cancer, drugs, promotion, monitoring, infectious diseases).

He was a Commission representative on the Board of the EU Lisbon Drugs Agency, and is currently the Commission representative on the Board of the European Centre for Disease Prevention and Control. He also had the charge of dealing with tobacco control issues.

Current priorities include the development of an EU cancer plan, antimicrobial resistance, vaccination policies, and the negotiation of financial instruments to support health, including research.

He has previously worked on the completion of the internal market, and on international trade negotiations. He is also an official of the Irish civil service (on leave). He is a fellow of the UK faculty of public health.

5 COCIR BREAST CANCER CARE 2020 COCIR SPEAKERS

Lydie MEHEUS

MANAGING DIRECTOR – ANTICANCER FUND Lydie Meheus is Managing Director of the Anticancer Fund (ACF), a Belgian Research Foundation of Public Utility with an international scope, dedicated to the development of cancer treatments regardless of their commercial value.

Lydie co-founded the Anticancer Fund in 2013 with entrepreneur and major funder Luc Verelst, after leading an alike Swiss organisation, Reliable Cancer Therapies, also initiated in 2009 by Luc Verelst. Lydie is still Executive Director of Reliable Cancer Therapies, today the collaborating partner of ACF for projects outside Europe.

Lydie is a breast cancer patient, diagnosed in 2018 and successfully treated since then. In 2019, Lydie was appointed by the European Commission as alternate to represent patients for 3 years in the Committee for Advanced Therapies (CAT) one of the seven committees at the European Medicines Agency (EMA). Lydie is also member of the Scientific and Clinical Advisory Board of OvaCure, a Danish non-profit organisation that supports research for breakthrough treatments in ovarian cancer.

She has published many international peer review manuscripts, lately on drug repurposing in cancer therapies. She obtained a PhD in Sciences at the University of Ghent (1986). She worked at Innogenetics (1987-2004) and as VP R&D at GENimmune (2005-2008), both Belgian biopharmaceutical companies.

Chrysoula ZACHAROPOULOU

MEMBER OF THE MEPS AGAINST CANCER INTEREST GROUP Ms Zacharopoulou is a Member of European Parliament (Renew Europe Group), elected in France, Vice-President of the Committee on Development (DEVE), Member of the Environment, Public Health and Food Safety (ENVI) committee, and Member of the Committee on Women’s rights and Gender equality (FEMM). She is a surgeon-gynaecologist by training. Born and raised in Greece, she studied in Rome, Italy where she completed a Medical Degree, in Strasbourg, France, where she took a specialisation in minimally invasive and robotic surgery, and finally a Master’s degree in Health management and policies from the Paris Institute of Political Studies.

Ms Zacharopoulou specialised on the research on the endometriosis disease. In France, she founded an association (“info-endometriose”) and led a national campaign in order to raise awareness on this underdiagnosed disease that affects 1 in 10 women. A strong advocate of sexual and reproductive health and rights of women and girls, Ms Zacharopoulou brought forward issues such as the empowerment of women and girls in rural areas, menstrual hygiene and painful menstruation to the Commission on Status of Women (CSW) of the United Nations in 2017 and 2018. She was appointed rapporteur on the Africa-EU strategy for the European Parliament.

6 COCIR BREAST CANCER CARE 2020 COCIR SPEAKERS

Prof. Francesco SARDANELLI

PROFESSOR OF RADIOLOGY, UNIVERSITY OF MILAN, RESEARCH HOSPITAL POLICLINICO SAN DONATO, MILAN, ITALY Professor Francesco Sardanelli was born in Genoa, Italy, in 1953. He graduated in Medicine (magna cum laude) in 1982 and completed his postgraduate studies in Radiodiagnostics (magna cum laude) at the University of Genoa, in 1986. He was a staff radiologist at the San Martino Hospital, Genoa, from 1987 to 1999, and was appointed Professor of the Postgraduation Course in Radiodiagnostics at the University of Genoa, from 1992 to 2000. Professor Sardanelli is Director of the Department of Radiology at the Research Hospital (IRCCS) Policlinico San Donato, Milan, from 2001 until today and was Professor of the Postgraduation Course in Radiodiagnostics at the University of Milan from 2001-2005. He was appointed Associate Professor of Radiology (2006-2014), continuing as Full Professor of Radiology until today at the University of Milan. He was also the Director of the Postgraduation School in Nuclear Medicine at the University of Milan (2008-2010). Since 2015, he is Director of the Postgraduation School in Radiodiagnostics at University of Milan.

Professor Sardanelli was a member of the Editorial/Advisory Board of the European Radiology from 2003-2006 and from 2012-2016. From 2013 to 2016, he was Associate Editor of Radiologia Medica. He is currently member of the editorial board of The Breast (2007-today), American Journal of Roentgenology (Assistant Editor, Womens’ Imaging Section, 2009-today) and Clinical and Translational Imaging (2014-today). From 2012 to 2016 he was a member of the editorial board of Insights into Imaging. Since 2016 he is Editor-in-Chief of the European Radiology Experimental. Moreover, he is reviewer for another 50 medical journals. To read more: https://www.eusobi.org/francesco-sardanelli/

Prof. Christiane KUHL

CHAIRMAN OF THE DEPARTMENT OF DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY AT THE UNIVERSITY HOSPITAL AACHEN (UKA), GERMANY

Prof. Dr. med. Christiane Katharina Kuhl was born in Bonn, Germany, in 1966. She studied medicine at the University of Bonn, Germany, and did her Ph.D. thesis on 31P MR spectroscopy in patients with mitochondrial encephalomyopathies with “summa cum laude” in 1992. She completed her residency training at the Department of Radiology, University of Bonn, in 1998. She is a board certified radiologist, neuroradiologist and interventional radiologist. She is certified and licensed to training the entire field of Interventional Radiology. She became associate professor in 1999, and full professor of Radiology and vice chairman of the Department of Radiology of Bonn University in 2004. In 2008, she was elected as member of the presidency of Bonn University (Pro-Rektor). In 2010, she joined the Technical University of Aachen (RWTH) to become Chairman and Director of the Department of Diagnostic and Interventional Radiology at the RWTH University Hospital Aachen. RWTH is one of the largest academic institutions in Germany, with a clear focus on research and development in the field of engineering and technology. It belongs to one of the few selected “excellence universities” in Germany. Prof. Kuhl is an internationally recognized expert in the field of breast cancer imaging with a special emphasis on the field of breast MRI. She has a long-standing track record in the diagnosis as well as the interventional treatment of cancer, and authored or co-authored well over 1000 papers and conference abstracts, including several highly-cited landmark papers on the use of MR imaging for breast cancer diagnosis. She served as Principal Investigator in several large single- and multi-institutional clinical trials studies. Her other main focus of interest is interventional oncology. To read more: https://www.eusobi.org/content-eusobi/uploads/CV-C.K.Kuhl_.pdf

7 COCIR BREAST CANCER CARE 2020 COCIR SPEAKERS

Prof. Youlia KIROVA, M.D.

ASSOCIATE PROFESSOR OF RADIATION ONCOLOGY, CURIE INSTITUTE, PARIS, FRANCE Since 2015 Prof. Kirova is Head of Breast Cancer Research and Treatment and Hematological Malignancies in the Department of Radiation Oncology, Curie Institute, Paris, France In 2009, Prof. Kirova became “HDR”: Professor of Radiotherapy, Radiobiology, Radio pathology, Paris V Univ. She is author of numerous publications (more than 290 PubMed), participation in books and a teacher in different European Schools, as ESTRO, ESO, ESSO. She is also member of ILROG Steering Committee and member of EORTC Radiotherapy, Breast and Hematological Groups. In addition she is vice president FROG (Francilian Oncogeriatric Group) and visiting Professor at Harvard University. To read more: https://institut-curie.org/personne/youlia-kirova

Christine MUZEL

COCIR VALUE IN HEALTH FOCUS GROUP VICE-CHAIR AND DIRECTOR MARKET ACCESS & REIMBURSEMENT AT PHILIPS

MedTech leader with focus on guiding E2E decision making through the lens of payers, policymakers and health technology assessment bodies. Her track record spans the breadth of the health technology industry from R&D to market adoption, in both functional roles and strategic leadership in start-up, business venture and international enterprise settings.

Dr. Christian STOECKIGT

COCIR MEMBER AND HEAD OF SCIENTIFIC AFFAIRS & MEDICAL EDUCATION AT HOLOGIC Dr. Christian Stoeckigt is a multilingual professional with over 12 years of experience in Medical Affairs, diagnostics, sales and business development with extensive experience coordinating global projects in the public and private sector. He is passionate about outcome driven and value based healthcare. He holds a MSc in biophysics and immunology and a PhD in Microbiology and Computer Science.

8 COCIR BREAST CANCER CARE 2020 COCIR SPEAKERS

Nicole DENJOY

COCIR SECRETARY GENERAL Nicole Denjoy is the COCIR Secretary General since 2005 and is based in Brussels. Nicole has gathered more than 35 years of experience in the medical technology industry, working for companies including L’air Liquide, Ohmeda, Boston Scientific and Baxter. Nicole has a Masters in Organisation and Change Management.

Nicole represents COCIR in a variety of influential fora at European Level as well as at international level. Nicole is also Chair of DITTA, the Global Trade Association representing Medical Imaging, Radiation Therapy and Healthcare IT Industry (www.globalditta.org) and leads the DITTA Industry voice in official relationships with WHO since DITTA was granted a NGO status in 2015 and leads the partnership between DITTA and the World Bank since 2016.

In addition, Nicole is Vice-Chair of the Business at OECD Health Committee representing the private business sector in front of the OECD Health Committee

Annemijn ESCHAUZIER

COCIR VALUE IN HEALTH FOCUS GROUP CHAIR AND CHIEF MARKETING OFFICER, WOMEN’S HEALTH AT GE HEALTHCARE

Annemijn joined the Women’s Health team in GE Healthcare Imaging as Chief Marketing Officer in September 2017. She is responsible for the growth strategy and commercial activation of the portfolio (Mammography & Bone Metabolic Health), working in partnership with Customers, Product Management and the Commercial Teams in the regions. Developing an integrated Breast care/ Breast cancer strategy is a key area of focus. Annemijn was Marketing Excellence and -Operations leader and member of the Global Marketing Leadership team from 2014 until taking up her current position. Prior to this Annemijn was Chief Marketing Officer for GE Healthcare for the EMEA region, later Europe since 2009 based in Buc, France.

Her first assignment in GEHC, which she joined in 2005, was building the Global Business Analysis organization, after spending 20+ years in marketing and specialist marketing roles. Most of her career before GE Healthcare has been spend at GSK.

9 COCIR BREAST CANCER CARE 2020 GENERAL INFORMATION ABOUT COCIR

COCIR is the European Trade Association representing the Our focus is to open markets for COCIR members in Europe and medical imaging, radiotherapy, health ICT and electromedical beyond. We provide a range of services in the areas of regulatory, industries. technical, market intelligence, environmental, standardisation, international and legal affairs. Founded in 1959, COCIR is a non-profit association headquartered in Brussels (Belgium) with a China Desk based COCIR is also a founding member of DITTA, the Global in Beijing since 2007. COCIR is unique as it brings together the Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade healthcare, IT and telecommunications industries. Association (www.globalditta.org).

COCIR COMPANY MEMBERS:

NATIONAL TRADE ASSOCIATIONS MEMBERS:

BELGIUM FRANCE GERMANY GERMANY GRAPHIC DESIGN

HUNGARY ITALY PORTUGAL THE NETHERLANDS THE NETHERLANDS OCTOBER 2020 / D-NICE